Cabaletta Bio (CABA) Cash from Operations (2018 - 2025)
Cabaletta Bio (CABA) recorded quarterly Cash from Operations of 35343000.0 in Q4 2025, down 2.42% quarter-over-quarter from 34509000.0 in Q3 2025, and down 52.85% on a YoY basis from 74965677.09 in Q4 2024.
Cabaletta Bio (CABA) Cash from Operations (2018 - 2025) Analysis & Trends
Cabaletta Bio's Cash from Operations history runs 8 years deep, the most recent figure standing at 35343000.0 for Q4 2025.
- In Q4 2025, Cash from Operations fell 52.85% year-over-year to 35343000.0; the TTM figure through Dec 2025 stood at 131080000.0 (down 48.58% YoY), while the FY2025 annual figure was 131080000.0, down 48.58% from the prior year.
- Cash from Operations was 35343000.0 for Q4 2025 at Cabaletta Bio, down from 34509000.0 in the prior quarter.
- In the past five years, Cash from Operations ranged from a high of 6580000.0 in Q2 2021 to a low of 35343000.0 in Q4 2025.
- Historically, Cash from Operations has averaged 17667000.0 across 5 years, with a median of 12708500.0 in 2022.
- The sharpest annual moves came in 2021 and 2024: Cash from Operations gained 13.9% in 2021, then sank 90.26% in 2024.
- A 5-year view of Cash from Operations shows it stood at 10515000.0 in 2021, then fell by 15.37% to 12131000.0 in 2022, then tumbled by 35.59% to 16448000.0 in 2023, then slumped by 40.58% to 23122000.0 in 2024, then plunged by 52.85% to 35343000.0 in 2025.
- The last three Cash from Operations figures came in at 35343000.0 (Q4 2025), 34509000.0 (Q3 2025), and 30426000.0 (Q2 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Ops. (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | -1.67 Mn |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | -12.20 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | -2.49 Mn |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 1.43 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | - |
| 10 | Cabaletta Bio | 151.84 Mn | 18.24 Mn | - | -35.34 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -35.34 Mn |
| Dec 31, 2025 | -35.34 Mn |
| Sep 30, 2025 | -34.51 Mn |
| Sep 30, 2025 | -34.51 Mn |
| Jun 30, 2025 | -30.43 Mn |
| Jun 30, 2025 | -30.43 Mn |
| Mar 31, 2025 | -30.80 Mn |
| Mar 31, 2025 | -30.80 Mn |
| Dec 31, 2024 | -23.12 Mn |
| Dec 31, 2024 | -23.12 Mn |
| Sep 30, 2024 | -20.32 Mn |
| Sep 30, 2024 | -20.32 Mn |
| Jun 30, 2024 | -20.79 Mn |
| Jun 30, 2024 | -20.79 Mn |
| Mar 31, 2024 | -23.99 Mn |
| Mar 31, 2024 | -23.99 Mn |
| Dec 31, 2023 | -16.45 Mn |
| Dec 31, 2023 | -16.45 Mn |
| Sep 30, 2023 | -12.60 Mn |
| Sep 30, 2023 | -12.60 Mn |